Welcome to the first edition of the BIOCRATES Newsletter!
This bi-monthly newsletter highlights the latest news about our company, products and services, actual developments in metabolomics, and publications. We will also provide you with an overview of upcoming events attended by BIOCRATES where you have an opportunity to meet with our team.
We hope you enjoy this first edition of the BIOCRATES Newsletter and welcome your feedback.
Company News: New company address and website
We would like to inform you that as of April, 1 2013 BIOCRATES has a new company address: Eduard-Bodem-Gasse 8, 6020 Innsbruck, Austria Our new fax number: +43.512.579 823 329. All other contact details remain the same.
BIOCRATES is also pleased to announce the release of its new company website, designed with a fresh new look and user-friendly navigation, updated with the latest information about our products and services.
Product News: AbsoluteIDQ p150 & p180 Kits: Available in 56-well-format
Now our metabolomics research Kits, AbsoluteIDQ p150 & p180, also feature a 56-well format for both manual and automated sample preparation. Our Kits are an excellent choice for researchers looking for a cost-effective solution to measure endogenous metabolites under quality-controlled conditions in their own lab. The AbsoluteIDQ Kits from BIOCRATES have been successfully applied in many different area, which include diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research.
Jahrestagung ÖKG (Österreichische Kardiologische Gesellschaft) 5-8 June, Salzburg, Austria
ASMS 2013 9-13 June, 2013, Minneapolis, USA, booth no 164
Scientific News: Latest papers
This section provides a short overview on the latest publications featuring BIOCRATES products:
"Targeted metabolomics profiles are strongly correlated with nutritional patterns in women"
"Metabolic Sigantures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism"
BIOCRATES Life Sciences AG is a leading biotechnology company focused on the development of ms-based metabolomics products as well as in vitro diagnostics (IVDs) for early disease detection and progression in areas such as nephrology, diabetes, oncology and endocrinology.
BIOCRATES Life Sciences AG Eduard-Bodem-Gasse 8, 6020 Innsbruck
If you no longer wish to receive the BIOCRATES Life Sciences AG email newsletter, please click here to unsubscribe. This email was sent by: BIOCRATES Life Sciences AG, Eduard-Bodem-Gasse 8, 6020 Innsbruck email@example.com Phone +43.512.579 823, Fax +43.512.579 823–329, FN 220414 p LG Innsbruck, UID No.: ATU 56725128